Your browser doesn't support javascript.
loading
Temporal Trends in Outcomes in Patients With Adrenocortical Carcinoma: A Multidisciplinary Referral-center Experience.
Daher, Marilyne; Varghese, Jeena; Gruschkus, Stephen K; Jimenez, Camilo; Waguespack, Steven G; Bedrose, Sara; Altameemi, Lina; Bazerbashi, Hadil; Naing, Aung; Subaiah, Vivek; Campbell, Matthew T; Shah, Amishi Y; Zhang, Miao; Sheth, Rahul A; Karam, Jose A; Wood, Christopher G; Perrier, Nancy D; Graham, Paul H; Lee, Jeffery E; Habra, Mouhammed Amir.
Afiliação
  • Daher M; Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
  • Varghese J; Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
  • Gruschkus SK; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
  • Jimenez C; Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
  • Waguespack SG; Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
  • Bedrose S; Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
  • Altameemi L; Division of Diabetes, Endocrinology, and Metabolism, Baylor College of Medicine, Houston, Texas 77030, USA.
  • Bazerbashi H; Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
  • Naing A; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
  • Subaiah V; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
  • Campbell MT; Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
  • Shah AY; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
  • Zhang M; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
  • Sheth RA; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
  • Karam JA; Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
  • Wood CG; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
  • Perrier ND; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030USA.
  • Graham PH; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
  • Lee JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
  • Habra MA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
J Clin Endocrinol Metab ; 107(5): 1239-1246, 2022 04 19.
Article em En | MEDLINE | ID: mdl-35092681
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Córtex Suprarrenal / Carcinoma Adrenocortical Tipo de estudo: Observational_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Córtex Suprarrenal / Carcinoma Adrenocortical Tipo de estudo: Observational_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article